← Back to catalogue

Lyra

FDA UDI

Class N (US FDA UDI)

by Diagnostic Hybrids, Inc.

Identity

Trade Name
Lyra FDA UDI
Generic Name
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Lyra SARS-CoV-2 Assay FDA UDI
Model / Reference
Coronavirus FDA UDI
Description
Lyra SARS-CoV-2 Assay FDA UDI

Identifiers

Catalog Number
M120 FDA UDI
Primary DI / UDI-DI
30014613339090 FDA UDI
FDA Product Code
QJR FDA UDI
GMDN Term
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
N FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)

Lyra by Diagnostic Hybrids, Inc. — Class N — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5dd59cc7-9d5e-47be-b753-ace445241fdc 35 fields · synced Jun 8, 2026